TARS1 and ovarian carcinoma: To validate the clinical links suggested by the database studies and the mechanistic links found in our angiogenesis study, we measured TARS expression in tissue sections from 70 human ovarian cancer specimens, of which 59 had 10 year patient survival information and 31 had matching pre-surgical serum samples [5].